0 Commentaires
0 Parts
645 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Cancer Treatment Drugs Market to Reach USD 359.83 Billion by 2032 Driven by Immunotherapy and Precision Oncology AdvancementsAccording to a report by Intel Market Research, the global cancer treatment drugs market was valued at USD 193.12 billion in 2024 and is projected to grow from USD 211.45 billion in 2025 to USD 359.83 billion by 2032, exhibiting a CAGR of 9.5% during the forecast period. The market is witnessing strong growth due to the rising global burden of cancer, increasing adoption of targeted therapies...0 Commentaires 0 Parts 786 Vue 0 Aperçu
-
Generic Oncology Drugs Market Segmentation Analysis: Insights by Drug Type, Indication, and Distribution ChannelThe global generic oncology drugs market is structured across multiple segments that reflect the diversity of cancer treatments and the evolving needs of patients and healthcare providers. Increasing demand for cost-effective therapies and the growing prevalence of various cancer types are driving growth across all segments. Generic Oncology Drugs Market Segmentation Analysis provides...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Immunotherapy Drugs Market Outlook: Growing Adoption Across Oncology and Autoimmune ApplicationsThe global immunotherapy drugs market is witnessing remarkable growth as demand for advanced and targeted treatment options surges across oncology, autoimmune diseases, and infectious diseases. Immunotherapy, which harnesses the body’s immune system to combat various illnesses, has emerged as a game-changing approach in modern medicine. Driven by a growing prevalence of chronic...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Oncology Drugs Market Outlook Fueled by Rising Global Cancer IncidenceThe global oncology drugs market is witnessing substantial growth as rising cancer incidence, expanding clinical research, and rapid advancements in targeted therapies and immuno-oncology continue to reshape cancer treatment. According to the latest market analysis, the global oncology drugs market was valued at USD 215.43 billion in 2025 and is projected to grow from USD 240.42 billion in 2026...0 Commentaires 0 Parts 71 Vue 0 Aperçu
-
Oncology Drugs Market: Growth, Trends & Forecast 2026–2034Market Overview The global Oncology Drugs Market is experiencing significant expansion, driven by the increasing global cancer burden and rapid advancements in pharmaceutical innovation. The market is projected to grow from approximately USD 253.6 billion in 2025 to USD 580.2 billion by 2033, registering a strong CAGR of 11.2%. Oncology drugs are designed to treat various...0 Commentaires 0 Parts 618 Vue 0 Aperçu
-
US Oncology Drugs Market Orphan Oncology Drugs and Niche Markets last 2024-2030US Oncology Drugs Market Report Overview: The aim of MMR's US Oncology Drugs Market report is to assist clients in making informed business decisions. This involves identifying areas that require improvement, recognizing already successful sectors, and aiding newcomers in navigating and establishing a competitive presence. Additionally, the report sheds light on the...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Dasatinib Market Forecast Based on Increasing Cancer Incidence WorldwideThe global Dasatinib Market was valued at USD 5.6 billion in 2025 and is projected to reach USD 7.6 billion by 2033, expanding at a CAGR of 4.3% from 2026 to 2033. The market is witnessing steady growth due to the increasing prevalence of hematologic cancers, particularly Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)....0 Commentaires 0 Parts 869 Vue 0 Aperçu
-
Advances in Oncology Research Driving the Metastatic Solid Tumors MarketComprehensive Outlook on Executive Summary Metastatic Solid Tumors Market Size and Share CAGR Value Data Bridge Market Research analyses a growth rate in the global metastatic solid tumors market in the forecast period 2022-2029 Metastatic Solid Tumors Market research report unearths different industry verticals such as company profile, contact details of manufacturer, product...0 Commentaires 0 Parts 5KB Vue 0 Aperçu
-
Antiemetics Market Growth Addressing Nausea Management Across Oncology and Postoperative CareGlobal Demand Outlook for Executive Summary Antiemetics Market Size and Share CAGR Value The global antiemetics market size was valued at USD 39.68 billion in 2025 and is expected to reach USD 61.87 billion by 2033, at a CAGR of 5.71% during the forecast period The wide-ranging report deals with the new business challenges and investment research on Antiemetics Marketwhich includes...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Carcinoid Syndrome Drug Market Gains Momentum with Advancements in Targeted TherapiesAccording to the latest report published by Data Bridge Market Research, the Carcinoid Syndrome Drug Market CAGR Value This Carcinoid Syndrome Drug Market research report is a resource, which offers current as well as upcoming technical and financial details of the Carcinoid Syndrome Drug Market industry for the specific forecast period. The report exhibits important product...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Commentaires 0 Parts 7KB Vue 0 Aperçu
-
Emerging Trends Influencing the Antibody Drug Conjugates MarketAsia-Pacific is expected to witness rapid growth in the coming years due to increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. Countries like China and India are emerging as important research hubs. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...0 Commentaires 0 Parts 10KB Vue 0 Aperçu
-
Endocrine Resistance–Targeting Drug Market Advances Through Breast Cancer ResearchAccording to the latest report published by Data Bridge Market Research, the Endocrine Resistance–Targeting Drug Market CAGR Value An excellent Endocrine Resistance–Targeting Drug Market research report is a great store to acquire current as well as upcoming technical and financial details and market insights of the Endocrine Resistance–Targeting Drug...0 Commentaires 0 Parts 186 Vue 0 Aperçu
-
Future Market Potential of Chemotherapy-Induced Peripheral Neuropathy TreatmentsThe global chemotherapy-induced peripheral neuropathy market size is projected to grow from US$ 1.01 billion in 2025 to approximately US$ 1.67 billion by 2034, reflecting a steady expansion. The market is anticipated to register a compound annual growth rate (CAGR) of around 5.71% during the forecast period, highlighting increasing investments in oncology supportive care. The...0 Commentaires 0 Parts 8KB Vue 0 Aperçu
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Commentaires 0 Parts 4KB Vue 0 Aperçu
Plus de résultats
© 2026 Myliveroom — Live Events & Online Communities
French